1. Home
  2. LGVN vs GRNQ Comparison

LGVN vs GRNQ Comparison

Compare LGVN & GRNQ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LGVN
  • GRNQ
  • Stock Information
  • Founded
  • LGVN 2014
  • GRNQ 2013
  • Country
  • LGVN United States
  • GRNQ Malaysia
  • Employees
  • LGVN N/A
  • GRNQ N/A
  • Industry
  • LGVN Medicinal Chemicals and Botanical Products
  • GRNQ EDP Services
  • Sector
  • LGVN Health Care
  • GRNQ Technology
  • Exchange
  • LGVN Nasdaq
  • GRNQ Nasdaq
  • Market Cap
  • LGVN 7.8M
  • GRNQ 7.8M
  • IPO Year
  • LGVN 2021
  • GRNQ 2018
  • Fundamental
  • Price
  • LGVN $4.39
  • GRNQ $0.87
  • Analyst Decision
  • LGVN Strong Buy
  • GRNQ
  • Analyst Count
  • LGVN 1
  • GRNQ 0
  • Target Price
  • LGVN $12.00
  • GRNQ N/A
  • AVG Volume (30 Days)
  • LGVN 24.4M
  • GRNQ 12.1K
  • Earning Date
  • LGVN 08-09-2024
  • GRNQ 08-09-2024
  • Dividend Yield
  • LGVN N/A
  • GRNQ N/A
  • EPS Growth
  • LGVN N/A
  • GRNQ N/A
  • EPS
  • LGVN N/A
  • GRNQ 0.09
  • Revenue
  • LGVN $978,000.00
  • GRNQ $3,498,328.00
  • Revenue This Year
  • LGVN $137.24
  • GRNQ N/A
  • Revenue Next Year
  • LGVN $50.77
  • GRNQ N/A
  • P/E Ratio
  • LGVN N/A
  • GRNQ $9.78
  • Revenue Growth
  • LGVN N/A
  • GRNQ N/A
  • 52 Week Low
  • LGVN $0.77
  • GRNQ $0.72
  • 52 Week High
  • LGVN $37.50
  • GRNQ $1.90
  • Technical
  • Relative Strength Index (RSI)
  • LGVN 71.83
  • GRNQ 37.68
  • Support Level
  • LGVN $3.80
  • GRNQ $0.96
  • Resistance Level
  • LGVN $6.40
  • GRNQ $1.08
  • Average True Range (ATR)
  • LGVN 0.53
  • GRNQ 0.08
  • MACD
  • LGVN 0.28
  • GRNQ -0.01
  • Stochastic Oscillator
  • LGVN 59.31
  • GRNQ 0.00

About LGVN Longeveron Inc.

Longeveron Inc is a clinical-stage biotechnology company developing regenerative medicines to address unmet medical needs for specific aging-related and life-threatening conditions. Its investigational product is Lomecel-B an stem cell formulation sourced from the bone marrow of young, healthy adult donors and has potential mechanisms of action that can promote tissue repair and healing. The company currently has three pipeline indications: Hypoplastic Left Heart Syndrome (HLHS), Alzheimer's disease (AD) and Aging-related Frailty.

About GRNQ Greenpro Capital Corp.

Greenpro Capital Corp operates and provides business solution services to small and medium-sized businesses located in Southeast Asia and East Asia, with a focus on Hong Kong, China and Malaysia, and in Thailand and Taiwan. Its range of services includes cross-border business solutions, record management services, and accounting outsourcing services. Cross-border business services include other services, tax planning, trust and wealth management, cross-border listing advisory services, and transaction services. It also operates a venture capital business. Its segments include Service business engaged in the provision of corporate advisory and business solution services; and Real estate business engaged in trading or leasing of commercial real estate properties in Hong Kong and Malaysia.

Share on Social Networks: